QQ客服 官方微博 反馈留言

	Discovery and Optimization of NAD(+)-Dependent DNA Ligase Inhibitors as Novel Antibacterial Compounds
	Bi, Fangchao; Ma, Ruixin; Ma, Shutao
刊名	CURRENT PHARMACEUTICAL DESIGN
	2017
卷号	23期号:14页码:2117-2130
关键词	DNA ligases LigAs inhibitors antibacterial HTS VS
DOI	10.2174/1381612822666161025145639
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4588656
专题	山东大学
作者单位	Shandong Univ, Sch Pharmaceut Sci, Minist Educ, Dept Med Chem,Key Lab Chem Biol, 44 West Culture Rd, Jinan 250012, Peoples
推荐引用方式 GB/T 7714	Bi, Fangchao,Ma, Ruixin,Ma, Shutao. Discovery and Optimization of NAD(+)-Dependent DNA Ligase Inhibitors as Novel Antibacterial Compounds[J]. CURRENT PHARMACEUTICAL DESIGN,2017,23(14):2117-2130.
APA	Bi, Fangchao,Ma, Ruixin,&Ma, Shutao.(2017).Discovery and Optimization of NAD(+)-Dependent DNA Ligase Inhibitors as Novel Antibacterial Compounds.CURRENT PHARMACEUTICAL DESIGN,23(14),2117-2130.
MLA	Bi, Fangchao,et al."Discovery and Optimization of NAD(+)-Dependent DNA Ligase Inhibitors as Novel Antibacterial Compounds".CURRENT PHARMACEUTICAL DESIGN 23.14(2017):2117-2130.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。